Hum Hered 2000;50:322–324

A Novel Missense Mutation, A118E, in the Helix Initiation Motif of the Type II Hair Cortex Keratin hHb6, Causing Monilethrix

Winter H.a · Vabres P.b · Larrègue M.b · Rogers M.A.a · Schweizer J.a
aGerman Cancer Research Center, Heidelberg, Germany, and bDepartment of Dermatology, University Hospital Center, Poitiers, France
email Corresponding Author

 goto top of outline Key Words

  • Keratin
  • Helix initiation motif
  • Mutation
  • Hair disease

 goto top of outline References
  1. Winter H, Rogers MA, Langbein L, Stevens HP, Leigh IM, Labrèze C, Roul S, Taieb A, Krieg T, Schweizer J: Mutations in the hair cortex keratin hHb6 cause the inherited hair disease monilethrix. Nature Genet 1997;16:372–374.
  2. Parry DAD, Steinert PM: IF Pathology: Molecular Consequences of Rod and End Domain Mutations; in Parry DAD, Steinert PM (eds): Intermediate Filament Structure, Molecular Biology Intelligence Unit. R.G. Landers Company Austin, Texas, Springer, New York, 1995, pp 145–175.
  3. Winter H, Clark RD, Tarras-Wahlberg C, Rogers MA, Schweizer J: Monilethrix: A novel mutation (Glu402Lys) in the helix termination motif and the first causative mutation (Asn114Asp) in the helix initiation motif of the type II hair keratin hHb6. J Invest Dermatol 1999;113:263–266.

 goto top of outline Author Contacts

Dr. Hermelita Winter
German Cancer Research Center, Research Program 2
Im Neuenheimerfeld 280
D–69120 Heidelberg (Germany)
Tel. +49 6221 423 248, Fax +49 6221 422 995, E-Mail

 goto top of outline Article Information

Received: Received: April 29, 1999
Accepted: May 19, 1999
Number of Print Pages : 3
Number of Figures : 2, Number of Tables : 0, Number of References : 3

 goto top of outline Publication Details

Human Heredity (International Journal of Human and Medical Genetics)
Founded 1950 as Acta Genetica et Statistica Medica by Gunnar Dahlberg; Continued by M. Hauge (1965–1983)

Vol. 50, No. 5, Year 2000 (Cover Date: September-October 2000 (Released June 2000))

Journal Editor: J. Ott, New York, N.Y.
ISSN: 0001–5652 (print), 1423–0062 (Online)

For additional information:

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.